Adding Brexit into the pandemic mix – clinical trials to continue...

Webinar - Free Q&A Session

Description

Event Webinar
Type Virtual Event
Language English
Date(s) 23 Nov. 2020
Day(s) 17:00 - 18:00
Duration 1 hour

Our Free of Charge weekly Q&A Webinars on Clinical Trials During the Corona Virus Pandemic are continuing!
Quality and ethics experts respond to your questions from sponsor and site points of view.


Adding Brexit into the pandemic mix – clinical trials to continue...


Agenda:

Updates on the MHRA guidelines and requirements post-BREXIT for clinical trials and drug safety

Perspective from a Subject Matter Expert - the EU QPPV

An opportunity to share questions and points to consider on BREXIT and the pandemic in parallel

Q&A, Discussions

Programme

17:00 Introduction to the Webinar
Moderator(s): Mark Poulton, Poulton Quality Solutions
Presentations
Louise Mawer, Mirabilitas Ltd
Sarah Hall, Mipsol Ltd
Q&A and Panel Discussion
Heather Sampson, University of Toronto
Hugh Davies, Oxford A Research Ethics Committee
18:00 End of the Webinar